A study testing whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help with weight.
- Who can join
- Adults 18+, have obesity.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long it lasts
- The study runs about 8 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
What this study is for
Primary condition: Obesity.
Full scientific study title: Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in Peop.
Who can join
Adults 18+, have obesity. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.
Full medical eligibility (for you and your doctor)verbatim from the registry
This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.
Key exclusion criteria
- Previous dosing in this study.
- Previous rescreening for this study.
- Female who is pregnant, breast-feeding or intends to become pregnant or is of childbearing potential and not using adequate contraceptive method
- Current participation (i.e., signed informed consent) in any other interventional clinical study.
- Exposure to investigational medicinal products, except maintenance treatment with liraglutide 3.0 mg, oral semaglutide 25 mg, or semaglutide 2.4 mg as required by the inclusion criterion, within 30 days or 5 half-lives of the investigational medicinal product (if known), which-ever is longer, before screening (Visit 1).
Where this study is enrolling
This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.
California1 site
- Altasciences Clinical LA, Inc.Cypress, California
Timeline
Started enrolling: 2025-11-07. Expected completion: 2026-07-17. Last updated on ClinicalTrials.gov: 2026-06-16.
Official source
We sync this data quarterly from ClinicalTrials.gov, the federal registry for clinical research. Before contacting a site, verify the trial is still recruiting on the official page:
Other GLP-1 clinical trials
Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.
